EXPLORE THE SCIENCE
TL;DR: A 2026 Nature Communications paper found that late-stage amyloid beta plaques in APP23 mice recruited CD8 T cells with a type I interferon program, linking Alzheimer-like amyloid pathology to a more adaptive immune response around plaques. Key Findings…
Read article
TL;DR: A 2026 study in Molecular Neurobiology found that Antrodia cinnamomea, a medicinal fungus extract, worked best when carried on citrate-stabilized silver nanoparticles in cell and rat models of Parkinson’s-like dopamine injury. Key Findings 6-OHDA create…
Read article
TL;DR: A 2026 protocol in PLOS One describes a 90-person pilot randomized controlled trial that will test whether virtual reality mindfulness can reduce depression, anxiety, stress, and caregiver burden in family caregivers of people with dementia. Key Finding…
Read article
TL;DR: A 2026 npj Parkinson’s Disease study used brain transcriptome data and genome-scale metabolic modeling to predict Parkinson’s metabolite biomarkers, including dopamine-related changes, and separated 104 postmortem samples into three metabolic clusters.…
Read article
TL;DR: A 2026 mouse study in Proceedings of the National Academy of Sciences found that deleting or inhibiting PTP1B improved memory behavior, reduced amyloid-beta burden, and pushed microglia toward an amyloid-clearing state. Key Findings Memory behavior impr…
Read article
TL;DR: A 2025 study in The Journal of Prevention of Alzheimer’s Disease found that stress internalization, not acculturation or activity engagement, predicted memory decline across three waves in 1,528 older Chinese Americans. Key Findings Stress internalizati…
Read article
TL;DR: A 2026 preprint longitudinal cohort analysis in medRxiv found that later-born cohorts showed higher memory levels entering old age and slower rates of memory decline, while the projected 20-year cohort advantage at age 80 was large enough in the model t…
Read article
TL;DR: A 2026 longitudinal analysis in the Journal of Affective Disorders tracked 635 older adults with new-onset loneliness and found that cognitive decline matched controls before loneliness began, then accelerated after onset, especially when loneliness per…
Read article
TL;DR: A 2026 preprint on medRxiv using the Harvard Biomarkers Study found that 43% of Parkinson’s disease patients had depression, anxiety, sleep apnea, or restless legs syndrome, compared with 21% of controls. Key Findings 1,224-person cohort: Researchers an…
Read article
TL;DR: A 2026 medRxiv preprint applied the AT(N) framework, an Alzheimer’s disease biomarker system for amyloid, tau, and neurodegeneration, to 84 older adults with focal epilepsy and found that only 32.1% had normal blood biomarkers, while early-onset epileps…
Read article